Cobra Biologics
Cobra Biologics is an international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply.
The company has three facilities in Sweden and the UK serving customers in the pharmaceutical and biotech industries around the world.
Cobra offers integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market.
Latest Cobra Biologics News & Features
8 April 2020
6 November 2019
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze